More recently, genome-wide searches for genetic alterations using whole-exome/genome sequencing have revealed that neuroblastomas, similarly to other pediatric malignancies, have very few additional gene targets, including ATRX, TERT, and RAS pathway genes [13–17]. The gene discussed is ATRX; the disease is neuroblastoma.